CoChat

Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse

Open access

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

To address the increasing demand for safe and effective treatment options for pelvic organ prolapse (POP) due to the worldwide ban of the traditional polypropylene meshes, this study introduced degradable polycaprolactone (PCL)/polyethylene glycol (PEG) composite meshes fabricated with melt-electrowriting (MEW). Two PCL/PEG mesh groups: 90:10 and 75:25 (PCL:PEG, wt%) were fabricated and characterized for their degradation rate and mechanical properties, with PCL meshes used as a control. The PCL/PEG composites showed controllable degradation rates by adjusting the PEG content and produced mechanical properties, such as maximal forces, that were higher than PCL alone. The antibacterial properties of the meshes were elicited by coating them with a commonly used antibiotic: azithromycin. Two dosage levels were used for the coating: 0.5 mg and 1 mg per mesh, and both dosage levels were found to be effective in suppressing the growth of S. aureus bacteria. The biocompatibility of the meshes was assessed using human immortalized adipose derived mesenchymal stem cells (hMSC). In vitro assays were used to assess the cell viability (LIVE/DEAD assay), cell metabolic activity (alamarBlue assay) and cell morphology on the meshes (fluorescent and electron microscopy). The cell attachment was found to decrease with increased PEG content. The freshly drug-coated meshes showed signs of cytotoxicity during the cell study process. However, when pre-released for 14 days in phosphate buffered saline, the initial delay in cell attachment on the drug-coated mesh groups showed full recovery at the 14-day cell culture time point. These results indicated that the PCL/PEG meshes with antibiotics coating will be an effective anti-infectious device when first implanted into the patients, and, after about 2 weeks of drug release, the mesh will be supporting cell attachment and proliferation. These meshes demonstrated a potential effective treatment option for POP that may circumvent the issues related to the traditional polypropylene meshes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym14040763

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The testing groups showing details on the sample material (PCL, 90:10, 75:25), geometry in terms of spacing and sample size, and state (top). The testing sequence is also shown with details of testing type, sample groupings and sample size (bottom).
Figure 1 The testing groups showing details on the sample material (PCL, 90:10, 75:25), geometry in terms of spacing and sample size, and state (top). The testing sequence is also shown with details of testing type, sample groupings and sample size (bottom).CC BY · PubMed Central
Figure 2 Physiological degradation (10 mL PBS at 37 °C) of PCL and PCL/PEG meshes (left). Accelerated degradation (10 mL 5 M NaOH at 37 °C) of PCL and PCL/PEG meshes (right). * shows significant less mass loss % in the PCL meshes compared to both PCL/PEG groups (n = 3, p < 0.05).
Figure 2 Physiological degradation (10 mL PBS at 37 °C) of PCL and PCL/PEG meshes (left). Accelerated degradation (10 mL 5 M NaOH at 37 °C) of PCL and PCL/PEG meshes (right). * shows significant less mass loss % in the PCL meshes compared to both PCL/PEG groups (n = 3, p < 0.05).CC BY · PubMed Central
Figure 3 Tensile testing results, including strength (yield strength (top left), ultimate tensile strength (top right) and max force per centimetre (bottom right)) and stiffness (Young’s modulus (bottom left)) measures for each grouping. Results are given in mean with error bar denoting standard deviation.
Figure 3 Tensile testing results, including strength (yield strength (top left), ultimate tensile strength (top right) and max force per centimetre (bottom right)) and stiffness (Young’s modulus (bottom left)) measures for each grouping. Results are given in mean with error bar denoting standard deviation.CC BY · PubMed Central
Figure 4 Cumulative antibiotic release profiles for the sample groups: (A) PCL groups, (B) 90:10 groups, (C) 75:25 groups.
Figure 4 Cumulative antibiotic release profiles for the sample groups: (A) PCL groups, (B) 90:10 groups, (C) 75:25 groups.CC BY · PubMed Central
Figure 5 Inhibition zone measurements for day 0 and day 14 for all testing groups (bottom). A representative image is shown of the testing plates (top), where clear inhibition zones can be seen for the fabricated meshes at day 0 and day 14 and for the positive control, whereas the mock loaded and unloaded negative controls did not exhibit the inhibition zone.
Figure 5 Inhibition zone measurements for day 0 and day 14 for all testing groups (bottom). A representative image is shown of the testing plates (top), where clear inhibition zones can be seen for the fabricated meshes at day 0 and day 14 and for the positive control, whereas the mock loaded and unloaded negative controls did not exhibit the inhibition zone.CC BY · PubMed Central
Figure 6 LIVE/DEAD assay and alamarBlue assay of all sample groups at all assessment time points. LIVE/DEAD assay results ((A) for PCL meshes, (C) for 90:10 meshes, (E) for 75:25 meshes) showing viable cells in green fluorescence. AlamarBlue results ((B) for PCL meshes, (D) for 90:10 meshes, (F) for 75:25 meshes) show mean± standard error mean (scale = 200 µm). In graph B and graph D, both non-loaded control group and drug released group showed significantly higher cell metabolic activity at the 14-day time point compared to the drug-loaded group. In graph F, significantly higher cell metabolic activity was found at the 14-day time point in the drug-released group compared to both the drug-loaded and non-loaded control groups. * shows statistical significance p < 0.05.
Figure 6 LIVE/DEAD assay and alamarBlue assay of all sample groups at all assessment time points. LIVE/DEAD assay results ((A) for PCL meshes, (C) for 90:10 meshes, (E) for 75:25 meshes) showing viable cells in green fluorescence. AlamarBlue results ((B) for PCL meshes, (D) for 90:10 meshes, (F) for 75:25 meshes) show mean± standard error mean (scale = 200 µm). In graph B and graph D, both non-loaded control group and drug released group showed significantly higher cell metabolic activity at the 14-day time point compared to the drug-loaded group. In graph F, significantly higher cell metabolic activity was found at the 14-day time point in the drug-released group compared to both the drug-loaded and non-loaded control groups. * shows statistical significance p < 0.05.CC BY · PubMed Central
Figure 7 MSC cell morphology on PCL mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.
Figure 7 MSC cell morphology on PCL mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.CC BY · PubMed Central
Figure 8 MSC cell morphology on 90:10 mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.
Figure 8 MSC cell morphology on 90:10 mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.CC BY · PubMed Central
Figure 9 MSC cell morphology on 75:25 mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.
Figure 9 MSC cell morphology on 75:25 mesh groups at all time points. Cell nuclei are shown in blue and cytoskeleton shown in green.CC BY · PubMed Central
Figure 10 MSC cell morphology by SEM on PCL mesh groups at all time points. Arrows pointing at representative cells or cell sheets attached on mesh fibres.
Figure 10 MSC cell morphology by SEM on PCL mesh groups at all time points. Arrows pointing at representative cells or cell sheets attached on mesh fibres.CC BY · PubMed Central
Figure 11 MSC cell morphology on PCL/PEG 90:10 mesh groups at all time points by SEM. Arrows pointing at representative cells or cell sheets attached on mesh fibres.
Figure 11 MSC cell morphology on PCL/PEG 90:10 mesh groups at all time points by SEM. Arrows pointing at representative cells or cell sheets attached on mesh fibres.CC BY · PubMed Central
Figure 12 MSC cell morphology on PCL/PEG 75:25 mesh groups at all time points by SEM. Arrows pointing at representative cells or cell sheets attached on mesh fibres.
Figure 12 MSC cell morphology on PCL/PEG 75:25 mesh groups at all time points by SEM. Arrows pointing at representative cells or cell sheets attached on mesh fibres.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 43

Metadata

Authors
Ren, J., Murray, R., Wong, C. S., Qin, J., Chen, M., Totsika, M., Riddell, A. D., Warwick, A., Rukin, N., & Woodruff, M. A.
Affiliations
  • Queensland University of Technology (AU)
  • The University of Queensland (AU)
  • St Vincent's Hospital Melbourne (AU)
  • Redcliffe Hospital (AU)
Corresponding author
Woodruff, Maria A.
Venue
Polymers
Publisher
MDPI AG
Published
2022-02-16
Volume
14
Issue
4
Pages
763
ISSN
2073-4360 (ISSN-L)
OpenAlex
W4213118871
Cited by
42
References
65
Citations by year
2026: 9 · 2025: 12 · 2024: 13 · 2023: 7 · 2022: 1
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Polymers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Metro North Hospital and Health Services; Queensland University of Technology (CRG 172-2019)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
  • Physical Sciences › Materials Science › Biomaterials › biodegradable polymer synthesis and properties
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
Keywords
pelvic organ prolapse, biodegradable mesh, polycaprolactone, polyethylene glycol, melt electrowriting, antimicrobial coatings, azithromycin, Staphylococcus aureus, mechanical properties, adipose-derived stem cells, biocompatibility, cytotoxicity, drug release

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse. https://app.cochat.ai/papers/10.3390/polym14040763
The paper
Ren, J., Murray, R., Wong, C. S., Qin, J., Chen, M., Totsika, M., Riddell, A. D., Warwick, A., Rukin, N., & Woodruff, M. A. (2022). Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse. Polymers. https://doi.org/10.3390/polym14040763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.